NAD+

NAD+ (nicotinamide adenine dinucleotide) is not a peptide but a vital coenzyme (a helper molecule) that hundreds of metabolic reactions in your cells cannot run without. It sits at the heart of the popular anti-aging conversation because its levels decline measurably with age. That observation is what every NAD+ precursor and direct NAD+ infusion tries to address.

What exactly is NAD+?

NAD+ is a dinucleotide (a molecule built from two smaller building blocks) that plays a central role in virtually every cell. It is the cell's main electron carrier in energy metabolism: imagine tiny charged particles being passed from one molecule to the next to deliver energy. It also supports the breakdown of carbohydrates and alcohol, activates sirtuins and PARPs for DNA repair and stress responses, and reaches especially high concentrations inside mitochondria.

It exists in two forms (oxidized NAD+ and reduced NADH) and participates as a coenzyme in hundreds of reactions in which electrons are swapped between molecules (called redox reactions). It fuels three large enzyme families: sirtuins (longevity regulators), PARPs (DNA-damage repair enzymes), and CD38/157 (enzymes for immune and calcium signaling). Without enough NAD+, these enzymes idle, and the "empty phone battery" metaphor fits surprisingly well.

From midlife on, NAD+ levels drop by roughly 10-25% in many tissues, alongside mitochondrial dysfunction and slower recovery. Every NAD+ strategy is essentially about recharging that battery.

What are the ways to raise NAD+?

Three approaches dominate today, each with different evidence behind it: oral precursors such as nicotinamide riboside (NR, brand name Niagen) and nicotinamide mononucleotide (NMN), intravenous NAD+ infusions given as a slow drip over several hours, and NAD+ shots injected under the skin (subcutaneous) offered by specialty clinics.

• Oral NAD+ precursors: Nicotinamide riboside (NR, brand name Niagen) and nicotinamide mononucleotide (NMN) are the most popular. NR has GRAS status in the US (Generally Recognized as Safe, meaning the FDA considers it safe) and is an approved novel food in the EU.
• Intravenous NAD+ infusions: Clinics offer 250-1000 mg NAD+ as a slow drip over hours, mainly for brain fog (mental fatigue), fatigue, and addiction protocols.
• Subcutaneous NAD+ shots: Less common, also through specialty clinics.

One important caveat: NAD+ taken by mouth is largely broken down in the gut. That is why oral strategies rely on precursors like NR or NMN, not the NAD+ molecule itself.

What do the studies show?

The data tell a split story: biochemically, NAD+ precursors like NR and NMN reliably and dose-dependently raise blood NAD+ in humans, while clinically meaningful health gains such as lower blood pressure, reduced inflammation, or better endurance are smaller and more inconsistent in humans than in animal models.

• Safety: NR is well-tolerated for 12 weeks at doses up to 1000 mg/day (no flushing [skin redness], no liver enzyme rise; however, some studies suggest NR and NMN may raise LDL cholesterol [the so-called "bad" cholesterol]). NAD+ infusions commonly trigger nausea, sweating, and cramps, especially at higher rates.
• Efficacy (cardiovascular): In healthy older adults, chronic NR reliably raises blood NAD+ and modestly lowers systolic blood pressure. Whether comparable effects on blood pressure, inflammation (measured by CRP, C-reactive protein), or carotid artery wall thickness (a marker of arterial stiffness and cardiovascular risk), as reported in large meta-analyses of nicotinic acid (niacin) at 2 g/day or more, also apply to NR or NMN remains unproven, since adequately powered studies are lacking.
• Efficacy (muscle and metabolism): Older men show moderate improvements in muscle parameters, while insulin sensitivity data (how well cells respond to the blood-sugar hormone insulin) in prediabetes are mixed. Effects on endurance and insulin sensitivity are smaller in humans than in mice.
• Direct NAD+ infusions: Early pilot work suggests infusions can briefly raise NAD+ levels. Clinically proven anti-aging effects are still missing.

Why do precursors work less in humans than in animals?

The gap between striking effects in rodent studies and the modest human results is called the translation problem in research (the difficulty of transferring animal findings to humans). It explains a large part of the disappointment many users feel after their first few months of supplementation, because animal data do not transfer one-to-one to humans.

Mice and rats receive high doses per body weight, have short lifespans, uniform lab diets, and tightly defined disease models. Humans are genetically more diverse, live far longer, and carry chronic background burdens. The dramatic anti-aging effects seen in rodents therefore do not translate one-to-one to humans, and hard clinical endpoints such as lifespan extension or disease prevention (in other words, concrete measurable outcomes like death or a new diagnosis) remain unproven in healthy adults.

How is NAD+ typically taken?

Most NAD+ supplements are actually NR or NMN capsules dosed between 100 and 1000 mg per day, clinical IV infusions usually sit at 250-1000 mg per session over 1-6 hours, and none of these amounts is a clinically validated therapeutic dose, especially not without medical supervision.

That is not a dosing recommendation, because the evidence base is still too thin for that, and you should treat any protocol claim with skepticism. Practical handling notes for research chemicals live in the Peptigraph guides.

Lifestyle: protecting NAD+ without supplements

Before reaching for capsules or infusions, it pays to look at free levers, because a healthy lifestyle with sufficient sleep aligned to your circadian rhythm, regular exercise, and an antioxidant-rich diet can lower daily NAD+ consumption and meaningfully support your body's own regeneration processes.

Adjunct approaches such as interval hypoxia-hyperoxia therapy (IHHT, a breathing protocol that alternates between low and high oxygen levels) are also discussed, but the scientific evidence for them remains thin. If you already take NAD+ precursors, treat these basics as amplifiers rather than replacements.

Legal status and warning about IV infusions

In the EU the rules are clear but rarely noticed: NR is approved as a food supplement with a maximum of 300 mg per day for adults, though EFSA explicitly excludes pregnant and breastfeeding women from this approval. NMN is currently not approved as a food supplement, and NAD+ infusions outside medical supervision are problematic for several distinct reasons.

Pure NAD+ sits in a regulatory gray zone: its status as an ingredient in food supplements is not clearly defined, and in other foods it counts as an unauthorized novel food ingredient. Anyone wanting to buy higher doses or NMN legally as a supplement in the EU therefore runs into a regulatory gap.

Urgent warning about NAD+ infusions outside medical supervision: They are not evidence-based as an anti-aging therapy and rely on animal data plus a handful of small human pilot studies that show no clinical benefit. In wellness studios without a doctor on site, there is a real medical risk because the substance given intravenously is not side-effect-free (nausea, cramps, circulatory reactions). If you have chronic conditions, take medication, or are pregnant, medical advice is mandatory before any supplementation.

Safety, gray market, and alternatives

NAD+ as a powder, capsule, or IV drip is not prescription-only, but it sits in very different regulatory gray zones depending on country and form, and online purchases carry real risks of adulteration, mislabeling, and underdosing. These issues are documented in detail in Peptigraph's Vendor Radar to help you avoid costly mistakes.

If you want to compare NAD+ with other mitochondrial strategies, look at SS-31 (elamipretide, another peptide that targets mitochondria) and MOTS-c (a second mitochondrial peptide), where SS-31 has solid clinical data, while MOTS-c so far is mainly supported by animal studies.

Common questions (FAQ)

Here are the two most common questions curious users google about NAD+ that marketing usually answers very differently from the current evidence: does NAD+ actually help with weight loss, and is NR or NMN the smarter choice for everyday supplementation in the EU?

Does NAD+ help with weight loss? Systematic reviews of NAD+ precursors such as nicotinic acid and nicotinamide have looked at weight loss and related hormones, but a clear, reproducible human benefit has not emerged. Anyone using NAD+ primarily for fat loss should keep expectations realistic.

NR or NMN - which is better? Both precursors measurably raise NAD+ in humans, and there is no clear clinical winner. In the EU, NR is legally available as a supplement; NMN is not, and that is the decisive practical difference for many users. Consumers should seek medical advice before starting either.